
BUY MBP ZOLEDRONIC ACID BLAZTERE 4MG INJ VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM
₦96,525.00
Description
Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Medicine name: Zoledronic acid
Brand name: Zometa or Aclasta, depending on indication
Zoledronic acid is an intravenous medicine belonging to a group of drugs called bisphosphonates. It is commonly used in patients with cancer that has spread to the bones, as well as in certain non-cancer conditions such as osteoporosis or Paget?s disease of bone. In cancer care, its main role is to strengthen bones, reduce bone pain, and lower the risk of complications such as fractures, spinal cord compression, or the need for surgery or radiotherapy to the bones.
Bone is a living tissue that is constantly being broken down and rebuilt. In conditions such as metastatic cancer or osteoporosis, this balance is disrupted, leading to excessive bone breakdown. Zoledronic acid works by inhibiting the activity of cells called osteoclasts, which are responsible for bone resorption. By slowing down bone breakdown, the medicine helps maintain bone strength and stability.
Zoledronic acid is given as an intravenous infusion, usually over at least 15 minutes, in a hospital or clinic setting. The dosing schedule depends on the reason it is prescribed. In cancer-related bone disease, it is often given every three to four weeks. In osteoporosis, it may be given once yearly. The exact schedule will be determined by the treating doctor.
Before each infusion, blood tests are required to check kidney function and calcium levels. Zoledronic acid is cleared through the kidneys, and impaired kidney function increases the risk of adverse effects. Adequate hydration before and after the infusion is important, unless the doctor has advised fluid restriction for another medical reason.
Patients are usually advised to take calcium and vitamin D supplements while on zoledronic acid, unless contraindicated. This helps prevent low calcium levels in the blood, which can occur because the medicine reduces calcium release from bones.
Common side effects often occur within the first few days after the infusion and may resemble flu-like symptoms. These include fever, chills, muscle aches, joint pain, headache, and fatigue. These reactions are usually mild to moderate and tend to improve within a few days. Simple pain relief such as paracetamol is often sufficient and may be recommended before or after the infusion.
Zoledronic acid can cause low calcium levels in the blood. Symptoms of low calcium include tingling around the mouth or in the fingers and toes, muscle cramps, muscle spasms, or, in severe cases, irregular heartbeat or seizures. Patients should be advised to seek medical attention promptly if these symptoms occur.
Kidney-related side effects are an important consideration. Patients should report reduced urine output, swelling in the legs, or sudden weight gain. The medicine may be withheld or dose-adjusted if kidney function deteriorates.
A rare but serious side effect is osteonecrosis of the jaw. This condition involves delayed healing or breakdown of the jawbone and is more likely to occur in patients receiving zoledronic acid for cancer, especially after dental extractions or invasive dental procedures. Patients should have a dental check-up before starting treatment where possible, maintain good oral hygiene, and inform their dentist that they are receiving zoledronic acid. Any jaw pain, swelling, loose teeth, or non-healing mouth sores should be reported immediately.
Another rare complication is atypical fractures of the thigh bone with long-term use. Patients should be advised to report new or unusual pain in the thigh, hip, or groin area.
Zoledronic acid may interact with other medicines that affect kidney function or calcium levels. Patients should inform their pharmacist or doctor about all medicines they are taking, including over-the-counter products and supplements.
Zoledronic acid is not recommended during pregnancy or breastfeeding. Women of childbearing potential should discuss contraception with their healthcare provider if relevant.
In summary, zoledronic acid is an effective treatment for strengthening bones and preventing serious bone-related complications in both cancer and non-cancer conditions. Safe use relies on appropriate kidney and calcium monitoring, adequate hydration, calcium and vitamin D supplementation, and awareness of potential side effects. Patients should be encouraged to attend all scheduled blood tests and infusions and to promptly report any concerning symptoms to their healthcare team.
You must be logged in to post a review.
General Inquiries
There are no inquiries yet.
There are no reviews yet.